Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism and non-alcoholic steatohepatitis(NASH) developed in liver-specific SREBP1c transgenic mice fed high-fat and high-fructose diet

Toshiyasu Sasaoka

Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism and non-alcoholic steatohepatitis(NASH) developed in liver-specific SREBP1c transgenic mice fed high-fat and high-fructose diet

^*Corresponding author for this work

Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	824-828
Number of pages	5
Journal	Therapeutic Research
Volume	33
Issue number	6
State	Published - 2012

ASJC Scopus subject areas

General Medicine

Cite this

@article{4acce2a0439640f58a239417244590eb,

title = "Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism and non-alcoholic steatohepatitis(NASH) developed in liver-specific SREBP1c transgenic mice fed high-fat and high-fructose diet",

author = "Toshiyasu Sasaoka",

year = "2012",

language = "英語",

volume = "33",

pages = "824--828",

journal = "Therapeutic Research",

issn = "0289-8020",

publisher = "Life Science Publishing Co. Ltd",

number = "6",

}

TY - JOUR

T1 - Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism and non-alcoholic steatohepatitis(NASH) developed in liver-specific SREBP1c transgenic mice fed high-fat and high-fructose diet

AU - Sasaoka, Toshiyasu

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84863861705&partnerID=8YFLogxK

M3 - 学術論文

AN - SCOPUS:84863861705

SN - 0289-8020

VL - 33

SP - 824

EP - 828

JO - Therapeutic Research

JF - Therapeutic Research

IS - 6

ER -